These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16828808)

  • 1. Antipsychotic induced metabolic abnormalities: an interaction study with various PPAR modulators in mice.
    Arulmozhi DK; Dwyer DS; Bodhankar SL
    Life Sci; 2006 Oct; 79(19):1865-72. PubMed ID: 16828808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
    Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
    Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
    Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
    J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
    Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
    Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of subchronic clozapine administration on serum glucose, cholesterol and triglyceride levels, and body weight in male BALB/c mice.
    Cheng CY; Hong CJ; Tsai SJ
    Life Sci; 2005 Mar; 76(19):2269-73. PubMed ID: 15733941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
    Wang ZJ; Liu Q; Li PP; Zou CH; Shen ZF
    Eur J Pharmacol; 2008 Feb; 580(1-2):277-83. PubMed ID: 18048028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats.
    Murashita M; Kusumi I; Hosoda H; Kangawa K; Koyama T
    Psychoneuroendocrinology; 2007 Aug; 32(7):777-84. PubMed ID: 17629416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
    Liu Z; Li J; Zeng Z; Liu M; Wang M
    Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
    Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M
    Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet.
    Fernandes-Santos C; Evangelista Carneiro R; de Souza Mendonca L; Barbosa Aguila M; Mandarim-de-Lacerda CA
    Pancreas; 2009 Apr; 38(3):e80-6. PubMed ID: 19214135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
    Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of adiponectin by natural and synthetic phenolamides in mouse and human preadipocytes and its enhancement by docosahexaenoic acid.
    Yamazaki Y; Kawano Y; Uebayasi M
    Life Sci; 2008 Jan; 82(5-6):290-300. PubMed ID: 18166202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
    Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
    Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation.
    Tulipano G; Rizzetti C; Bianchi I; Fanzani A; Spano P; Cocchi D
    Neuroendocrinology; 2007; 85(2):61-70. PubMed ID: 17374945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice.
    Jatwa R; Parmar HS; Panda S; Kar A
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):177-80. PubMed ID: 17697037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of clozapine on glucose metabolism.
    Yazici KM; Erbas T; Yazici AH
    Exp Clin Endocrinol Diabetes; 1998; 106(6):475-7. PubMed ID: 10079027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.